Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968156930> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W1968156930 endingPage "e79684" @default.
- W1968156930 startingPage "e79684" @default.
- W1968156930 abstract "Objective To describe the characteristics of randomized controlled clinical trials (RCT) on cancer drugs conducted in Spain between 1999 and 2003 based on their protocols. Methods We conducted an observational retrospective cohort study to identify the protocols of RCTs on cancer drugs authorized by the Agencia Española del Medicamento y Productos Sanitarios (AEMPS) (Spanish Agency for Medicines and Medical Devices) during 1999-2003. A descriptive analysis was completed and the association between variables based on the study setting and sponsorship were assessed. Results We identified a total of 303 protocols, which included 176,835 potentially eligible patients. Three-quarter of the studies were internationally-based, 61.7% were phase III, and 76.2% were sponsored by pharmaceutical companies. The most frequently assessed outcomes were response rate (24.7%), overall survival (20.7%), and progression-free survival (14.5%). Of all protocols, 10.6% intended to include more than 1000 patients (mean: 2442, SD: 2724). Compared with their national counterparts, internationally-based studies were significantly larger (p<0.001) and were more likely to implement centralized randomization (p<0.001), blinding of the intervention (p<0.001), and survival as primary outcome (p<0.001). Additionally, most internationally-based studies were sponsored by pharmaceutical companies (p<0.01). In a high percentage of protocols, the available information was not explicit enough to assess the validity of each trial. Compared to other European countries, the proportion of Spanish cancer drugs protocols registered at www.clinicaltrials.gov (7%) was lower. Conclusion RCTs on cancer drugs conducted in Spain between 1999 and 2003 were more likely to be promoted by pharmaceutical companies rather than by non-profit national groups. The former were more often part of international studies, which generally had better methodological quality than national ones. There are some worldwide on-going initiatives that aim to increase the transparency and quality of future research." @default.
- W1968156930 created "2016-06-24" @default.
- W1968156930 creator A5000269330 @default.
- W1968156930 creator A5014239140 @default.
- W1968156930 creator A5014434734 @default.
- W1968156930 creator A5015111495 @default.
- W1968156930 creator A5037716407 @default.
- W1968156930 creator A5070889333 @default.
- W1968156930 date "2013-11-13" @default.
- W1968156930 modified "2023-10-12" @default.
- W1968156930 title "Description of the Protocols for Randomized Controlled Trials on Cancer Drugs Conducted in Spain (1999–2003)" @default.
- W1968156930 cites W1969788117 @default.
- W1968156930 cites W1973497290 @default.
- W1968156930 cites W1976366538 @default.
- W1968156930 cites W1988851494 @default.
- W1968156930 cites W2014234827 @default.
- W1968156930 cites W2017857169 @default.
- W1968156930 cites W2037674853 @default.
- W1968156930 cites W2040980580 @default.
- W1968156930 cites W2043983323 @default.
- W1968156930 cites W2064638166 @default.
- W1968156930 cites W2068790072 @default.
- W1968156930 cites W2082342518 @default.
- W1968156930 cites W2083315419 @default.
- W1968156930 cites W2087266312 @default.
- W1968156930 cites W2101281162 @default.
- W1968156930 cites W2116996240 @default.
- W1968156930 cites W2127887787 @default.
- W1968156930 cites W2133874926 @default.
- W1968156930 cites W2166023752 @default.
- W1968156930 doi "https://doi.org/10.1371/journal.pone.0079684" @default.
- W1968156930 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3827456" @default.
- W1968156930 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24236154" @default.
- W1968156930 hasPublicationYear "2013" @default.
- W1968156930 type Work @default.
- W1968156930 sameAs 1968156930 @default.
- W1968156930 citedByCount "4" @default.
- W1968156930 countsByYear W19681569302016 @default.
- W1968156930 countsByYear W19681569302018 @default.
- W1968156930 countsByYear W19681569302019 @default.
- W1968156930 countsByYear W19681569302022 @default.
- W1968156930 crossrefType "journal-article" @default.
- W1968156930 hasAuthorship W1968156930A5000269330 @default.
- W1968156930 hasAuthorship W1968156930A5014239140 @default.
- W1968156930 hasAuthorship W1968156930A5014434734 @default.
- W1968156930 hasAuthorship W1968156930A5015111495 @default.
- W1968156930 hasAuthorship W1968156930A5037716407 @default.
- W1968156930 hasAuthorship W1968156930A5070889333 @default.
- W1968156930 hasBestOaLocation W19681569301 @default.
- W1968156930 hasConcept C121608353 @default.
- W1968156930 hasConcept C126322002 @default.
- W1968156930 hasConcept C168563851 @default.
- W1968156930 hasConcept C17744445 @default.
- W1968156930 hasConcept C199539241 @default.
- W1968156930 hasConcept C204243189 @default.
- W1968156930 hasConcept C23131810 @default.
- W1968156930 hasConcept C2771230 @default.
- W1968156930 hasConcept C2779473830 @default.
- W1968156930 hasConcept C3020340455 @default.
- W1968156930 hasConcept C512399662 @default.
- W1968156930 hasConcept C535046627 @default.
- W1968156930 hasConcept C71924100 @default.
- W1968156930 hasConceptScore W1968156930C121608353 @default.
- W1968156930 hasConceptScore W1968156930C126322002 @default.
- W1968156930 hasConceptScore W1968156930C168563851 @default.
- W1968156930 hasConceptScore W1968156930C17744445 @default.
- W1968156930 hasConceptScore W1968156930C199539241 @default.
- W1968156930 hasConceptScore W1968156930C204243189 @default.
- W1968156930 hasConceptScore W1968156930C23131810 @default.
- W1968156930 hasConceptScore W1968156930C2771230 @default.
- W1968156930 hasConceptScore W1968156930C2779473830 @default.
- W1968156930 hasConceptScore W1968156930C3020340455 @default.
- W1968156930 hasConceptScore W1968156930C512399662 @default.
- W1968156930 hasConceptScore W1968156930C535046627 @default.
- W1968156930 hasConceptScore W1968156930C71924100 @default.
- W1968156930 hasIssue "11" @default.
- W1968156930 hasLocation W19681569301 @default.
- W1968156930 hasLocation W19681569302 @default.
- W1968156930 hasLocation W19681569303 @default.
- W1968156930 hasLocation W19681569304 @default.
- W1968156930 hasLocation W19681569305 @default.
- W1968156930 hasOpenAccess W1968156930 @default.
- W1968156930 hasPrimaryLocation W19681569301 @default.
- W1968156930 hasRelatedWork W1989626097 @default.
- W1968156930 hasRelatedWork W2002981128 @default.
- W1968156930 hasRelatedWork W2029114449 @default.
- W1968156930 hasRelatedWork W2089908284 @default.
- W1968156930 hasRelatedWork W2160817671 @default.
- W1968156930 hasRelatedWork W2275660195 @default.
- W1968156930 hasRelatedWork W2986082864 @default.
- W1968156930 hasRelatedWork W4206060654 @default.
- W1968156930 hasRelatedWork W4238788738 @default.
- W1968156930 hasRelatedWork W2781743445 @default.
- W1968156930 hasVolume "8" @default.
- W1968156930 isParatext "false" @default.
- W1968156930 isRetracted "false" @default.
- W1968156930 magId "1968156930" @default.
- W1968156930 workType "article" @default.